Tag: CDSCO

Eli Lilly and Company India has announced the launch of Tanstrive (selpercatinib) in India, following marketing authorisation from the Central Drugs Standard Control Organization...

Eli Lilly and Company (India) has announced the launch of Lormalzi (donanemab, 350 mg/20 mL IV vial) in India, following marketing authorization from the...

MSN Laboratories announced the launch of Semabest, its semaglutide brand, in the Indian market following approval from the Central Drugs Standard Control Organisation (CDSCO). This...

India’s pharmacy and healthcare sector has emerged as one of the most dynamic industries in the world, driven by a growing population, increasing healthcare...

Hyderabad based Hetero Biopharma has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture the Russian Covid vaccine Sputnik Light for...

The ministry of Health and Family Welfare has decided to extend the date of implementation of the unique device identification (UDI) of medical devices,...

ASPA and Messe Frankfurt India united senior leaders and industry experts for a panel discussion on “Protecting the lives and pharmaceutical supply chain during...

While the Government and Industry are trying their best to make available a safe and effective vaccine for Covid-19 at the earliest, it is...

Hyderabad-based Bharat Biotech has successfully developed COVAXIN, India’s 1st vaccine candidate for Covid-19, in collaboration with the Indian Council of Medical Research (ICMR) -...